Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity. - Wikidata - wikimedia - TriplyDB

Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.

Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.

http://www.wikidata.org/entity/Q34742607

about

Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1 Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1 The restriction factors of human immunodeficiency virus Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all The APOBEC3 family of retroelement restriction factors Suppression of APOBEC3-mediated restriction of HIV-1 by Vif Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n Extremely High Mutation Rate of HIV-1 In Vivo Cellular superspreaders: an epidemiological perspective on HIV infection inside the body Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.Cytidine deaminase efficiency of the lentiviral viral restriction factor APOBEC3C correlates with dimerization.A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.Retroelements versus APOBEC3 family members: No great escape from the magnificent seven Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein Host restriction factors in retroviral infection: promises in virus-host interaction.Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.APOBECs and virus restriction.Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.The Structural Interface between HIV-1 Vif and Human APOBEC3H.Lentivirus restriction by diverse primate APOBEC3A proteins.Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population.Deamination-independent restriction of LINE-1 retrotransposition by APOBEC3H The role of cytidine deaminases on innate immune responses against human viral infections.Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution

P2860

Q21144862-FC037260-B7EB-4171-B504-127B334BB085 Q24310242-82164E98-B151-4657-8459-4D9AA22179C9 Q24321636-CB73708D-560E-4291-B1CD-BAB8B721A685 Q24605108-B71D408E-3AC6-4DC5-BF40-BA0C99F5F675 Q26781812-DAC0D039-970E-4051-B3F7-5998F2AC298E Q26823568-A39DC168-2CE1-40D8-816F-6D1074EC552F Q26862780-91F78DF8-BC45-4B79-9E7A-41DFD1A49F37 Q27025150-E6BA9895-ED41-4CDA-B692-4C27A4D4E4C6 Q28481286-06759FA9-049A-4712-AE9F-B3CED27FFEAE Q28548089-CFB2DFB0-A210-4DFC-A8EB-FEEC84AA416C Q28657772-8E270FCC-4462-4154-8BB8-58823E2FE00D Q31078477-9063F2DD-DED6-48CB-B631-C696A073BE99 Q33558327-E1785B4A-576F-4FEF-9FFD-669E24301E80 Q33651576-ADE58F62-3B8C-462D-9114-723F4D81165D Q33699581-9C81A42D-00C6-4F3A-9689-169E8D5613B8 Q33982561-80FEFF32-2502-4DA6-B7FF-50A0C61633CB Q34261416-DD141216-9B7B-4A60-A225-678FD33176B7 Q34612416-CDB97905-1D4A-4763-B75E-7DCAA48FA165 Q35068754-9F04E924-DCEA-41A5-890C-5021F90F0686 Q35666084-21BECB0B-D617-44AF-9821-8D3F9E1DCFA2 Q36031782-5C063E86-87FD-4E77-AFD2-6CCD35D589A6 Q36162443-078611E4-5386-494D-ADB2-9425ACAF08E3 Q36283884-E898F950-EE1B-4B13-9E33-D1D5A649AB42 Q36432758-1431504E-7038-4F14-A0FC-DFA72E33A150 Q36548179-FCB86208-810A-47BE-AD52-C974465B7891 Q36724272-A2EAD6DE-5B2D-419B-B1AF-6C5997BA3255 Q36811931-95F2F73A-CB85-4A87-A46E-58A12ACF85C8 Q37281847-956A873D-E58D-4C90-8042-F8F0DD4AF66E Q37593180-85B815CD-E650-4754-A69D-366B348FB019 Q38394187-A89685E6-36A8-441C-8A74-5593BE7E54E6 Q38879828-1C8667D2-A109-4834-8A63-027EFC8285F9 Q39056653-0AE5593D-0CF3-4642-9E6A-CA814BBE9987 Q39155683-1FC347B5-DD4D-4950-9D00-EF81CCE259EE Q40212174-FF4BBCF9-1802-4F48-9948-142E7622FD6C Q40618088-009531FA-870B-4967-ACF2-0C74E0388147 Q40913460-2D1FF42B-A77A-43DF-9BA7-5FB4DEBFCAF2 Q41539251-2E15A944-462B-46FC-817C-E8BD5FC02C8C Q41812539-BBB7E5E7-47BF-42D4-80D9-EBF9E49FDECF Q41900176-2CC3CA30-78DC-4EA2-A30A-71DE84C602FF Q42041441-5E82C0D4-CB0C-43E5-AAC0-ADF6C237BC9A

P2860

Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.

http://www.wikidata.org/entity/Q34742607

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@ast

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@en

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@nl

type

label

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@ast

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@en

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@nl

prefLabel

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@ast

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@en

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@nl

P1433

Q34742607-AEAE6F9D-5532-449D-9F96-67AFA1C61DC3

P1476

Q34742607-95751E65-F7B6-4919-8BF2-175A32CDC15C

P2093

Q34742607-4552AA20-5B69-4B58-B132-5C63E934B860

Q34742607-8882D986-49A3-4B84-94AA-F2360A793CBE

Q34742607-9A2CBCCB-B2A5-46F2-BAB0-5CBCAE9E1050

Q34742607-B7EC4E0B-D4C8-48D9-A174-DE077C84047C

Q34742607-B95065FB-1417-4212-83DB-B8512A5109CC

Q34742607-D96BD9EF-5560-4755-AA2F-867D397D65AD

P2860

Q34742607-02524C42-EDAF-4D25-AD62-973834B14B72

Q34742607-02851125-FFA4-42C2-BDAC-8C2EA8D859C8

Q34742607-039D63C9-834E-43B4-8F9D-9E3BF185E3B5

Q34742607-04F6C249-2647-45E0-9E91-3A879624BDA5

Q34742607-0CA5308C-3729-4631-A5E4-F499D648923D

Q34742607-1279B501-5621-48F9-9D27-62DAEE502DDB

Q34742607-1D2CBF63-C977-41C3-BA99-5E8C15B27E80

Q34742607-2085D33C-669B-40AD-AD87-819FF05DD4FD

Q34742607-28A5A9A4-EA07-488C-8C1D-7647651676B9

Q34742607-2CD6A604-EA0D-4045-86A1-4859776A9067

P304

Q34742607-BC72A4ED-D63D-4045-B04D-FE5E4E385398

P31

Q34742607-095B4983-7964-4D40-8574-A05952AEC47B

P356

Q34742607-12683E75-F37C-455A-8097-B478F911CC52

P407

Q34742607-836C9856-94F9-4140-A00B-350857242669

P433

Q34742607-7C152DE6-1E71-42FB-9580-579CDBDD92F3

P478

Q34742607-E0D908D6-E4C4-4D41-9BCB-710A934014BA

P577

Q34742607-4F661A33-50EA-44B5-B1CE-E9B2C729F0D0

P5875

Q34742607-D6E9EAFC-6B9A-440E-AFE8-732D663416EC

P698

Q34742607-8F459882-6E39-41DE-AF17-0DADCFF7128D

P932

Q34742607-4C5D17A1-F639-45BD-975B-0FDECF03254D

P356

P1433

Journal of Virology

P1476

Analysis of human APOBEC3H hap ...... iciency virus type 1 activity.

@en

P2093

Aierken Abudu

http://www.w3.org/2001/XMLSchema#string

Patrick J Venta

http://www.w3.org/2001/XMLSchema#string

Sungmo Son

http://www.w3.org/2001/XMLSchema#string

Xiaojun Wang

http://www.w3.org/2001/XMLSchema#string

Ying Dang

http://www.w3.org/2001/XMLSchema#string

Yong-Hui Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Population stratification of a common APOBEC gene deletion polymorphism

A Draft Sequence of the Neandertal Genome

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

Antiretroelement activity of APOBEC3H was lost twice in recent human evolution

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity

A complete Neandertal mitochondrial genome sequence determined by high-throughput sequencing

P304

3142-3152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02049-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49788162

http://www.w3.org/2001/XMLSchema#string

P698

21270145

http://www.w3.org/2001/XMLSchema#string

P932

3067873

http://www.w3.org/2001/XMLSchema#string